Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Unity_Biotechnology
|
| https://www.w3.org/2000/01/rdf-schema#label |
UBX1325
|
| gptkbp:intendedUse |
treatment of diabetic macular edema
|
| gptkbp:mechanismOfAction |
Bcl-xL inhibitor
|
| gptkbp:routeOfAdministration |
intravitreal injection
|
| gptkbp:status |
investigational drug
|
| gptkbp:studiedBy |
age-related macular degeneration
diabetic retinopathy |
| gptkbp:target |
senescent cells
|
| gptkbp:bfsParent |
gptkb:Unity_Biotechnology
|
| gptkbp:bfsLayer |
5
|